A Study To Evaluate the Safety, Tolerance, Pharmacokinetics/Pharmacodynamics and Efficacy of SYHA1402 Tablets For the Treatment of Patients With Diabetic Peripheral Neuropathy in China
Clinical trial NCT05116111 · UNKNOWN
Trial details
- NCT number
- NCT05116111
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-31
- Primary completion
- 2023-05-15
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.